Surgery, Octreotide, Temozolomide, Bevacizumab, Radiotherapy, and Pegvisomant Treatment of an AIP Mutation‒Positive Child

CONTEXT: Inactivating germline mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene are linked to pituitary adenoma predisposition. Here, we present the youngest known patient with AIP-related pituitary adenoma. CASE DESCRIPTION: The patient presented at the age of 4 years with...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutta, Pinaki, Reddy, Kavita S, Rai, Ashutosh, Madugundu, Anil K, Solanki, Hitendra S, Bhansali, Anil, Radotra, Bishan D, Kumar, Narendra, Collier, David, Iacovazzo, Donato, Gupta, Prakamya, Raja, Remya, Gowda, Harsha, Pandey, Akhilesh, Devgun, Jagtar Singh, Korbonits, Márta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619489/
https://www.ncbi.nlm.nih.gov/pubmed/31125088
http://dx.doi.org/10.1210/jc.2019-00432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619489/
https://www.ncbi.nlm.nih.gov/pubmed/31125088
http://dx.doi.org/10.1210/jc.2019-00432

Ejemplares similares